市場調査レポート

商品コード

1673621

フォルスコリンの市場規模、シェア、成長分析、濃度別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Forskolin Market Size, Share, and Growth Analysis, By Concentration (Low Concentration (10%), Medium Concentration (20%-40%)), By Application (Allergy Treatment, Weight Management), By End-User, By Region - Industry Forecast 2025-2032

出版日: 2025年03月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

フォルスコリン市場規模は2023年に5億1,130万米ドルと評価され、2024年の5億6,396万米ドルから2032年には12億3,554万米ドルに拡大し、予測期間（2025-2032年）のCAGRは10.3%で成長する見通しです。

フォルスコリンは、代謝と炎症を制御するサイクリックAMPレベルを高める役割で知られ、減量サプリメントや喘息、湿疹、乾癬の治療薬として人気を集めています。その有効性と安全性についてはさらなる調査が必要であるにもかかわらず、アーユルヴェーダ医学とアロパシー医学の両方で使用されています。健康への関心が高まるにつれ、ハーブ製品に対する世界の需要が高まっていることを反映し、栄養補助食品、飲食品、化粧品向けにエキスの純度がさまざまに変化しています。北米、特に米国では、肥満率の上昇と自然な代替品への嗜好を背景に、フォルスコリンが90％以上の市場シェアでリードしています。APAC地域では、伝統的な薬草のルーツに支えられたインドが市場のトップを占めています。フォルスコリンが体組成の改善や喘息の改善に役立つ可能性があることが研究により示唆されており、その市場プレゼンスは成長する態勢にあります。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024）

主要企業プロファイル

Alchem International Ltd.（India）
Nutra Green Biotechnology Co., Ltd.（China）
Shaanxi Jiahe Phytochem Co., Ltd.（China）
Glentham Life Sciences（United Kingdom）
Flavour Trove（India）
Cymbio Pharma Pvt. Ltd.（India）
Alpspure Lifesciences Pvt. Ltd.（India）
Bioprex Labs（India）
Deccan Nutraceuticals Pvt. Ltd.（India）
Ennature Biopharma（India）
Sunpure Extracts Pvt. Ltd.（India）
Sabinsa Corporation（United States）
Indena S.p.A.（Italy）
ChromaDex Corp.（United States）
Herbal Nutrition LLC（United States）
Himalaya Wellness（India）
Life Extension（United States）
Nature's Way Products, LLC（United States）
Swanson Health Products, Inc.（United States）
NOW Foods（United States）

結論と提言

Product Code: SQMIG35I2123

Forskolin Market size was valued at USD 511.3 million in 2023 and is poised to grow from USD 563.96 million in 2024 to USD 1235.54 million by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

Forskolin, known for its role in enhancing cyclic AMP levels-which regulates metabolism and inflammation-has gained traction as a weight loss supplement and treatment for asthma, eczema, and psoriasis. Despite the need for more research on its efficacy and safety, its use spans both Ayurvedic and allopathic medicine. Variations in extract purity cater to dietary supplements, food and beverages, and cosmetics, reflecting a growing global demand for herbal products as health concerns escalate. In North America, particularly the U.S., forskolin leads with over 90% market share, driven by rising obesity rates and the preference for natural alternatives. In the APAC region, India tops the market, supported by its traditional medicinal roots. As studies suggest forskolin's potential in improving body composition and aiding asthma, its market presence is poised for growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Forskolin market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Forskolin Market Segments Analysis

Global Forskolin Market is segmented by Concentration, Application, End-User and region. Based on Concentration, the market is segmented into Low Concentration (10%), Medium Concentration (20%-40%) and High Concentration (95%). Based on Application, the market is segmented into Allergy Treatment, Weight Management, Respiratory Problems, Cardiovascular Disorders, Glaucoma, Hypothyroidism, Psoriasis and Others. Based on End-User, the market is segmented into Nutraceuticals, Pharmaceuticals, Dietary Supplements and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Forskolin Market

A key factor propelling the Forskolin market is the surging demand for natural health supplements. Forskolin, extracted from the root of the Coleus forskohlii plant, has a long history in traditional medicine for treating various health issues. As consumers become more aware of the benefits associated with natural products and express growing concerns about the adverse effects of synthetic pharmaceuticals, the appeal of Forskolin supplements is on the rise. Additionally, the increasing incidence of chronic illnesses like obesity and cardiovascular diseases is further bolstering the market, as Forskolin is widely regarded as a safe and effective option for managing such health challenges.

Restraints in the Forskolin Market

A significant challenge facing the Forskolin market is the absence of regulation and standardization in the manufacturing and distribution processes of Forskolin products. As the demand for natural health supplements has surged, a wide array of Forskolin products has flooded the market, many of which may not adhere to established quality and safety standards. This situation poses a risk for consumers who might end up purchasing products that are not only ineffective but could also be detrimental to their health. Additionally, the lack of regulation leads to inconsistencies in the potency and purity of these products, resulting in varying therapeutic benefits, which undermines consumer trust and market stability.

Market Trends of the Forskolin Market

The forskolin market is experiencing a notable trend driven by a growing preference for natural and herbal remedies among health-conscious consumers. As more individuals seek alternatives to synthetic chemicals, forskolin-derived from the Coleus forskohlii plant-has gained traction for its potential health benefits, including weight management and metabolic improvement. This increasing awareness is further fueled by the rising prevalence of lifestyle-related conditions such as obesity and diabetes, prompting consumers to explore natural solutions. Additionally, the market is becoming increasingly competitive, with new entrants pushing innovation and the development of diverse, innovative forskolin products, thereby amplifying the market's growth trajectory.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Forskolin Market Size by Concentration & CAGR (2025-2032)

Market Overview
Low Concentration (10%)
Medium Concentration (20%-40%)
High Concentration (95%)

Global Forskolin Market Size by Application & CAGR (2025-2032)

Market Overview
Allergy Treatment
Weight Management
Respiratory Problems
Cardiovascular Disorders
Glaucoma
Hypothyroidism
Psoriasis
Others

Global Forskolin Market Size by End-User & CAGR (2025-2032)

Market Overview
Nutraceuticals
Pharmaceuticals
Dietary Supplements
Others

Global Forskolin Market Size & CAGR (2025-2032)

North America (Concentration, Application, End-User)
- US
- Canada
Europe (Concentration, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Concentration, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Concentration, Application, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Concentration, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Alchem International Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nutra Green Biotechnology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shaanxi Jiahe Phytochem Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Glentham Life Sciences (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flavour Trove (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cymbio Pharma Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alpspure Lifesciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioprex Labs (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Deccan Nutraceuticals Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ennature Biopharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sunpure Extracts Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sabinsa Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indena S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ChromaDex Corp. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Herbal Nutrition LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Himalaya Wellness (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Life Extension (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nature's Way Products, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Swanson Health Products, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NOW Foods (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

フォルスコリンの市場規模、シェア、成長分析、濃度別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

Forskolin Market Size, Share, and Growth Analysis, By Concentration (Low Concentration (10%), Medium Concentration (20%-40%)), By Application (Allergy Treatment, Weight Management), By End-User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

フォルスコリンの市場規模：濃度別& CAGR（2025-2032）

フォルスコリンの市場規模：用途別& CAGR（2025-2032）

フォルスコリンの市場規模：エンドユーザー別& CAGR（2025-2032）

フォルスコリン市場規模：地域別& CAGR（2025-2032）